Superluminal Medicines

Accelerating new possibilities in drug discovery and development

Superluminal Medicines is headquartered in Boston, United States, lists 11–50 employees, and has 2 recorded funding rounds.

Employees
11–50
Business Model
Other
Rounds
2

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

Superluminal Medicines is a Boston-based generative biology and chemistry company revolutionizing drug discovery with its Hyperloop™ Platform. This platform integrates cutting-edge structure-based drug discovery, AI-powered computational methods, and experimental validation to develop small molecule therapeutics targeting GPCRs for cardiometabolic diseases. Recently, they announced a collaboration with Eli Lilly potentially worth up to $1.3 billion.

Summary

Superluminal Medicines is a Life Sciences company based in Boston, United States. It lists 11–50 employees. Investors include RA Capital Management, Insight Partners and Catalio Capital Management.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries A

Sign up to see all 2 events

Funding, valuations, and company events, with amounts and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
PHC

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

Minato, Japan5001–10000Healthcare, Life Sciences
Private EquityTotal funding$1.9BMar 2021

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Superluminal Medicines on Indexed.vc
<a href="https://indexed.vc/companies/superluminal-medicines"><img src="https://indexed.vc/api/badge/company/superluminal-medicines" alt="Superluminal Medicines on Indexed.vc" width="260" height="76" /></a>